Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BrUOG 295: Adjuvant FOLFOX-A For Resected Pancreatic Cancer
NCT02022033Phase 2Completed
- Sponsor
- Brown University
- Start
- Feb 2014
- Primary completion
- Jul 2019
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nab-paclitaxel in pancreatic cancer (PC), sponsored by Brown University. Started Feb 2014; status: completed.
02
Drugs
nab-paclitaxel
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT02022033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02022033.